Health Care
Earnings preview: New product launches in focus as Teva gets ready for Q1 report
Teva Pharmaceutical (NYSE: TEVA) has long endued uncertainties in business even as the generic drug maker continued its efforts to…
CVS Health posts upbeat Q1 earnings, Q2 forecast
CVS Health Corporation (NYSE: CVS) reported a 43% jump in earnings for the first quarter of 2019 helped by the…
Earnings: Humana Q1 profit climbs on strength of Medicare biz; lifts FY19 guidance
Healthcare service provider Humana, Inc. (NYSE: HUM) Wednesday reported better than expected earnings and revenues for the first quarter, helped…
Amgen Q1 earnings beat Street view; lifts full-year earnings guidance
Biotechnology firm Amgen (Nasdaq: AMGN) reported first-quarter earnings that increased from last year and exceeded estimates, while revenues remained unchanged. Meanwhile,…
Pfizer Q1 profit tops expectations; raises FY19 earnings outlook
Pharma giant Pfizer (NYSE: PFE) Tuesday reported stronger than expected earnings and revenues for the first quarter of 2019. The…
KEYTRUDA helps Merck to report Q1 earnings beat, raises 2019 outlook
Shares of the pharma giant Merck (MRK) rose 2% before the market hours after the company surpassed estimates on the…
Cancer drugs boost AstraZeneca results in Q1
Riding on the strong demand for its cancer drugs, AstraZeneca Plc (NYSE: AZN) on Friday reported its third consecutive quarter…
The question every pot investor asks himself – Aurora Cannabis or Hexo?
If you have already missed the train, there is no denying the fact that NOW is the time to enter…
Earnings preview: Medical devices to drive Abbott Q1 results
Abbott Laboratories (NYSE: ABT) is scheduled to report its earnings results for the first quarter of 2019 on Wednesday before…